SOUTH SAN FRANCISCO, Calif. (AP) _ NGM Biopharmaceuticals Inc. (NGM) on Tuesday reported a loss of $15.9 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of 24 cents per share.
The biotechnology company posted revenue of $31.1 million in the period.
For the year, the company reported a loss of $42.8 million, or 85 cents per share. Revenue was reported as $103.5 million.
NGM Biopharmaceuticals shares have fallen 40% since the beginning of the year.